Letter re: A Pre-post Intervention Study Examining the Impact of a Novel Process on Administration Time for Emergent 23.4% Hypertonic Sodium Chloride Boluses

J Pharm Pract. 2024 Dec 20:8971900241310993. doi: 10.1177/08971900241310993. Online ahead of print.
No abstract available

Keywords: 23.4% sodium chloride; hypertonic saline; neurocritical care; preparation.

Publication types

  • Letter